Research And Development Activities

Modalis Therapeutics Corporation - Filing #7571290

Concept 2022-01-01 to
2022-12-31
Research and development activities
Research and development expenses
Research and development expenses
1,861,709,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.